REPLIGEN CORP Operating Income Loss

• REPLIGEN CORP showed an increase of +257.1% in Operating Income Loss from 2024 to 2025.
• This data is from REPLIGEN CORP's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), REPLIGEN CORP's Operating Income Loss has grown by 1,056.7%.
• Historical annual values: Fiscal year 2025: $55.17 million | Fiscal year 2024: -$35.11 million | Fiscal year 2023: $47.70 million | Fiscal year 2022: $224.67 million | Fiscal year 2021: $167.25 million | Fiscal year 2020: $69.82 million | Fiscal year 2019: $36.08 million | Fiscal year 2018: $25.99 million | Fiscal year 2017: $14.01 million | Fiscal year 2016: $15.97 million | Fiscal year 2015: $13.76 million | Fiscal year 2014: $10.69 million | Fiscal year 2013: $22.87 million | Fiscal year 2012: $11.08 million | Fiscal year 2011: -$374.1 thousand | Fiscal year 2010: -$5.77 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026